Dr. Reddy's Laboratories Limited Share Price and Company Fundamentals
Last traded: Today at 10:00 AM
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. The Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids with the customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; and research and development of differentiated formulations. The company offers its products for various therapeutic categories, including gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology, vaccines and pain management. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
Key Metrics
PE ratio
19.34
PB ratio
2.94
Dividend yield
0.62%
Beta
0.31
Market cap
₹1093.77B
Enterprise value
₹1082.11B
Company profile
| Industry / Sector | Drug Manufacturers - Specialty & Generic / Healthcare |
|---|---|
| Full time employees | 27811 |
| Website | https://www.drreddys.com |
| Mailing address | 8-2-337, Road No. 3 Banjara Hills Hyderabad 500034 India |
| Phone / Fax | 91 40 4900 2900 / |
Dividends
Dividend yield
0.62%
Dividend amount
₹8.00
Payout ratio
11.79%
5Y Avg. yield
-%
Dr. Reddy's Laboratories Limited paid ₹8.00 dividend and the ex-dividend date was 10 Jul 2025.The dividend payout ratio is 11.79%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.DRREDDY dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Mar 2026, following are the company executives and directors listed on Dr. Reddy's Laboratories Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Gunupati Venkateswara Prasad B.E. | Co-Chairman, MD & Member of Management Council | 65 | |
| Mr. Kallam Satish Reddy B.Tech., M.S. | Chairman of the Board & Member of the Management Council | 58 | |
| Mr. Erez Israeli M.B.A. | CEO & Member of the Management Council | 57 | |
| Mr. Mannam Venkatanarasimham | CFO & Member of the Management Council | 56 | |
| Mr. Krishna K. Venkatesh B.Pharma M.S. | Global Head of Quality and Pharmacovigilance & Member of the Management Council | 52 | |
| Mr. Deepak Sapra M.B.A. | Global Head of Pharmaceutical Services and Active Ingredients & Member of Management Council | 50 | |
| Mr. Motupalli Venkata Ramana M.B.A. | CEO of Branded Markets - India & Emerging Countries and Member of Management Council | 56 | |
| Ms. Archana Bhaskar B.Sc., M.B.A. | EVP, Head of Corporate Communications & Member of Management Council | 58 | |
| Mr. Sanjay Sharma B.Tech. | Executive VP, Global Head of Global Manufacturing & Member of Management Council | 57 | |
| Mr. Patrick Aghanian B.A., M.B.A. | Head of Generics, Europe & Consumer Health and Member of Management Council | 60 |
Profitability and management effectiveness
Profit margin
16.36%
Operating margin
16.42%
Return on assets
7.96%
Return on equity
16.10%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Dr. Reddy's Laboratories Limited is 1093.77B and its enterprise value is 1082.11B. The enterprise value to revenue ratio of DRREDDY is 3.13. The enterprise value to EBITDA ratio of DRREDDY is 12.76.
The DRREDDY's stocks Beta value is 0.31 making it 69% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Frequently Asked Questions
1. What is Dr. Reddy's Laboratories Limited's Stock Symbol?
Dr. Reddy's Laboratories Limited trades on NSE under the ticker symbol "DRREDDY".
2. What is Dr. Reddy's Laboratories Limited's stock price today?
One share of DRREDDY stock can currently be purchased for approximately ₹1313.5.
3. How can I contact Dr. Reddy's Laboratories Limited?
Dr. Reddy's Laboratories Limited's mailing address is 8-2-337, Road No. 3 Banjara Hills Hyderabad 500034 India. The company can be reached via phone at 91 40 4900 2900.
4. What is Dr. Reddy's Laboratories Limited's official website?
The official website of Dr. Reddy's Laboratories Limited is https://www.drreddys.com.